118 related articles for article (PubMed ID: 17685615)
1. Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin.
Liu CC; Brustad E; Liu W; Schultz PG
J Am Chem Soc; 2007 Sep; 129(35):10648-9. PubMed ID: 17685615
[No Abstract] [Full Text] [Related]
2. pH dependence of the interaction of hirudin with thrombin.
Betz A; Hofsteenge J; Stone SR
Biochemistry; 1992 Feb; 31(4):1168-72. PubMed ID: 1734964
[TBL] [Abstract][Full Text] [Related]
3. Impact of protein-protein contacts on the conformation of thrombin-bound hirudin studied by comparison with the nuclear magnetic resonance solution structure of hirudin(1-51).
Szyperski T; Güntert P; Stone SR; Tulinsky A; Bode W; Huber R; Wüthrich K
J Mol Biol; 1992 Dec; 228(4):1206-11. PubMed ID: 1474586
[TBL] [Abstract][Full Text] [Related]
4. Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.
De Simone G; Lombardi A; Galdiero S; Nastri F; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V
Protein Sci; 1998 Feb; 7(2):243-53. PubMed ID: 9521099
[TBL] [Abstract][Full Text] [Related]
5. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.
Chirgadze NY; Sall DJ; Klimkowski VJ; Clawson DK; Briggs SL; Hermann R; Smith GF; Gifford-Moore DS; Wery JP
Protein Sci; 1997 Jul; 6(7):1412-7. PubMed ID: 9232642
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the N-terminal region of hirudin with the active-site cleft of thrombin.
Betz A; Hofsteenge J; Stone SR
Biochemistry; 1992 May; 31(19):4557-62. PubMed ID: 1581311
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for the inhibition of thrombin by hirudin.
Stone SR; Betz A; Parry MA; Jackman MP; Hofsteenge J
Adv Exp Med Biol; 1993; 340():35-49. PubMed ID: 8154342
[No Abstract] [Full Text] [Related]
8. From natural to synthetic multisite thrombin inhibitors.
Lombardi A; De Simone G; Galdiero S; Staiano N; Nastri F; Pavone V
Biopolymers; 1999; 51(1):19-39. PubMed ID: 10380350
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.
Krishnan R; Tulinsky A; Vlasuk GP; Pearson D; Vallar P; Bergum P; Brunck TK; Ripka WC
Protein Sci; 1996 Mar; 5(3):422-33. PubMed ID: 8868478
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fluid phase and clot-bound thrombin by the thrombin exosite I ligand LU 58463: comparison with heparin and hirudin.
Filippucci E; Agnelli G; Leone M; Nenci GG
Haematologica; 2002 Oct; 87(10):1116-7. PubMed ID: 12368171
[No Abstract] [Full Text] [Related]
11. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.
Skrzypczak-Jankun E; Carperos VE; Ravichandran KG; Tulinsky A; Westbrook M; Maraganore JM
J Mol Biol; 1991 Oct; 221(4):1379-93. PubMed ID: 1942057
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolution.
Chen Z; Li Y; Mulichak AM; Lewis SD; Shafer JA
Arch Biochem Biophys; 1995 Sep; 322(1):198-203. PubMed ID: 7574675
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of RGD-hirudin binding to thrombin: Tyr3 and five C-terminal residues are crucial for inhibiting thrombin activity.
Huang Y; Zhang Y; Zhao B; Xu Q; Zhou X; Song H; Yu M; Mo W
BMC Struct Biol; 2014 Dec; 14():26. PubMed ID: 25526801
[TBL] [Abstract][Full Text] [Related]
14. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling studies of novel retro-binding tripeptide active-site inhibitors of thrombin.
Lau WF; Tabernero L; Sack JS; Iwanowicz EJ
Bioorg Med Chem; 1995 Aug; 3(8):1039-48. PubMed ID: 7582978
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6.
Zdanov A; Wu S; DiMaio J; Konishi Y; Li Y; Wu X; Edwards BF; Martin PD; Cygler M
Proteins; 1993 Nov; 17(3):252-65. PubMed ID: 8272424
[TBL] [Abstract][Full Text] [Related]
17. 3-Nitrotyrosine as a spectroscopic probe for investigating protein protein interactions.
De Filippis V; Frasson R; Fontana A
Protein Sci; 2006 May; 15(5):976-86. PubMed ID: 16641485
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-hirudin complex stability: a comparison with the thrombin-antithrombin III complex.
Römisch J; Pâques EP
Blood Coagul Fibrinolysis; 1991 Oct; 2(5):643-6. PubMed ID: 1782334
[TBL] [Abstract][Full Text] [Related]
19. [Hirudin inhibition of human thrombin activity].
Ascenzi P; Bolognesi M; Coletta M; Menegatti E; Amiconi G
Medicina (Firenze); 1990; 10(4):391-2. PubMed ID: 2099980
[TBL] [Abstract][Full Text] [Related]
20. Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
Martin PD; Malkowski MG; DiMaio J; Konishi Y; Ni F; Edwards BF
Biochemistry; 1996 Oct; 35(40):13030-9. PubMed ID: 8855938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
